Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for hepatoma
Most Relevant Literature
- Clinical value of identifying genes that inhibit hepatocellular carcinomas.
- MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver.
- Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients w…
- Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
- Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers.
Most Relevant Clinical Trials
- Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy
- Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
- Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy
- Combined Radiotherapy and Sorafenib in Patients With Hepatoma
- Taiwan ACE Beads for Hepatoma Embolization Therapy
